CARLSBAD, Calif., April 21 /PRNewswire/ -- PhotoThera Inc. announced today that is has closed a $30.5 million round of Series C venture funding. Participating investors included Delphi Ventures, DeNovo Ventures, Hamilton BioVentures, Warburg Pincus, The Vertical Group, and Solstice Capital.
"We are privileged to have such a high caliber group of investors, and would like to welcome Warburg Pincus as a new investor in PhotoThera," said Thomas Wilder, President & Chief Executive Officer. "We will utilize these funds to pursue continued development of our NeuroThera(TM) device for the treatment of patients with ischemic stroke."
About PhotoThera Inc.
PhotoThera Inc. develops innovative new technology using infrared laser energy for the treatment of ischemic stroke.
CONTACT: Jackson Streeter M.D., Founder and Executive Chairman ofPhotoThera Inc., +1-760-496-3700, ext. 104